<PAGE>
-------------------------------------
OMB APPROVAL
-------------------------------------
OMB Number: 3235-0145
Expires: October 31, 1997
Estimated average burden
hours per response: 14.90
-------------------------------------
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
------------------
SCHEDULE 13G/A
INFORMATION STATEMENT PURSUANT TO RULES 13d-1 AND 13d-2
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(AMENDMENT NO. 2)*
INTEGRA LIFESCIENCES CORPORATION
- -------------------------------------------------------------------------------
(Name of Issuer)
COMMON STOCK
- -------------------------------------------------------------------------------
(Title of Class of Securities)
457985 10 9
- -------------------------------------------------------------------------------
(CUSIP Number)
------------------
- -------------------
* The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities,
and for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 ("Act") or otherwise subject to the liabilities of that section of
the Act but shall be subject to all other provisions of the Act (however, see
the Notes).
Page 1 of 36
<PAGE>
CUSIP NO. 457985 10 9 13G/A Page 2 of 36 Pages
- -------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Richard E. Caruso, Ph.D.
- -------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [x]
(b) [ ]
- -------------------------------------------------------------------------------
3 SEC USE ONLY
- -------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
United States Citizen
- -------------------------------------------------------------------------------
NUMBER OF 5 SOLE VOTING POWER
SHARES
BENEFICIALLY 47,600
OWNED BY -----------------------------------------------------------
EACH 6 SHARED VOTING POWER
REPORTING
PERSON 14,401,611
WITH -----------------------------------------------------------
7 SOLE DISPOSITIVE POWER
47,600
-----------------------------------------------------------
8 SHARED DISPOSITIVE POWER
14,401,611
- -------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
14,449,211
- -------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
[ ]
- -------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
50.4%
- -------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
IN
- -------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
CUSIP NO. 457985 10 9 13G/A Page 3 of 36 Pages
- -------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Frances C. Holtz
- -------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [x]
(b) [ ]
- -------------------------------------------------------------------------------
3 SEC USE ONLY
- -------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
United States Citizen
- -------------------------------------------------------------------------------
NUMBER OF 5 SOLE VOTING POWER
SHARES
BENEFICIALLY 0
OWNED BY -----------------------------------------------------------
EACH 6 SHARED VOTING POWER
REPORTING
PERSON 14,358,411
WITH -----------------------------------------------------------
7 SOLE DISPOSITIVE POWER
0
-----------------------------------------------------------
8 SHARED DISPOSITIVE POWER
14,358,411
- -------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
14,358,411
- -------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
[ ]
- -------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
50.3%
- -------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
IN
- -------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
CUSIP NO. 457985 10 9 13G/A Page 4 of 36 Pages
- -------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Trust Partnership
- -------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [x]
(b) [ ]
- -------------------------------------------------------------------------------
3 SEC USE ONLY
- -------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Pennsylvania
- -------------------------------------------------------------------------------
NUMBER OF 5 SOLE VOTING POWER
SHARES
BENEFICIALLY 14,358,411
OWNED BY -----------------------------------------------------------
EACH 6 SHARED VOTING POWER
REPORTING
PERSON 0
WITH -----------------------------------------------------------
7 SOLE DISPOSITIVE POWER
14,358,411
-----------------------------------------------------------
8 SHARED DISPOSITIVE POWER
0
- -------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
14,358,411
- -------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
[ ]
- -------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
50.3%
- -------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
PN
- -------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
CUSIP NO. 457985 10 9 13G/A Page 5 of 36 Pages
- -------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Pagliacci Trust
- -------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [x]
(b) [ ]
- -------------------------------------------------------------------------------
3 SEC USE ONLY
- -------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Pennsylvania
- -------------------------------------------------------------------------------
NUMBER OF 5 SOLE VOTING POWER
SHARES
BENEFICIALLY 0
OWNED BY -----------------------------------------------------------
EACH 6 SHARED VOTING POWER
REPORTING
PERSON 14,358,411
WITH -----------------------------------------------------------
7 SOLE DISPOSITIVE POWER
0
-----------------------------------------------------------
8 SHARED DISPOSITIVE POWER
14,358,411
- -------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
14,358,411
- -------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
[ ]
- -------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
50.3%
- -------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
00
- -------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
CUSIP NO. 457985 10 9 13G/A Page 6 of 36 Pages
- -------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Rigoletto Trust
- -------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [x]
(b) [ ]
- -------------------------------------------------------------------------------
3 SEC USE ONLY
- -------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Pennsylvania
- -------------------------------------------------------------------------------
NUMBER OF 5 SOLE VOTING POWER
SHARES
BENEFICIALLY 0
OWNED BY -----------------------------------------------------------
EACH 6 SHARED VOTING POWER
REPORTING
PERSON 14,358,411
WITH -----------------------------------------------------------
7 SOLE DISPOSITIVE POWER
0
-----------------------------------------------------------
8 SHARED DISPOSITIVE POWER
14,358,411
- -------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
14,358,411
- -------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
[ ]
- -------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
50.3%
- -------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
00
- -------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
CUSIP NO. 457985 10 9 13G/A Page 7 of 36 Pages
- -------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Trust for Jonathan Henry Caruso
- -------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [x]
(b) [ ]
- -------------------------------------------------------------------------------
3 SEC USE ONLY
- -------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Pennsylvania
- -------------------------------------------------------------------------------
NUMBER OF 5 SOLE VOTING POWER
SHARES
BENEFICIALLY 0
OWNED BY -----------------------------------------------------------
EACH 6 SHARED VOTING POWER
REPORTING
PERSON 14,358,411
WITH -----------------------------------------------------------
7 SOLE DISPOSITIVE POWER
0
-----------------------------------------------------------
8 SHARED DISPOSITIVE POWER
14,358,411
- -------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
14,358,411
- -------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
[ ]
- -------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
50.3%
- -------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
00
- -------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
CUSIP NO. 457985 10 9 13G/A Page 8 of 36 Pages
- -------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Trust for Peter James Caruso
- -------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [x]
(b) [ ]
- -------------------------------------------------------------------------------
3 SEC USE ONLY
- -------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Pennsylvania
- -------------------------------------------------------------------------------
NUMBER OF 5 SOLE VOTING POWER
SHARES
BENEFICIALLY 0
OWNED BY -----------------------------------------------------------
EACH 6 SHARED VOTING POWER
REPORTING
PERSON 14,358,411
WITH -----------------------------------------------------------
7 SOLE DISPOSITIVE POWER
0
-----------------------------------------------------------
8 SHARED DISPOSITIVE POWER
14,358,411
- -------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
14,358,411
- -------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
[ ]
- -------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
50.3%
- -------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
00
- -------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
CUSIP NO. 457985 10 9 13G/A Page 9 of 36 Pages
- -------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Provco Leasing Corporation
- -------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [x]
(b) [ ]
- -------------------------------------------------------------------------------
3 SEC USE ONLY
- -------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
- -------------------------------------------------------------------------------
NUMBER OF 5 SOLE VOTING POWER
SHARES
BENEFICIALLY 43,200
OWNED BY -----------------------------------------------------------
EACH 6 SHARED VOTING POWER
REPORTING
PERSON 14,358,411
WITH -----------------------------------------------------------
7 SOLE DISPOSITIVE POWER
43,200
-----------------------------------------------------------
8 SHARED DISPOSITIVE POWER
14,358,411
- -------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
14,401,611
- -------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
[ ]
- -------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
50.4%
- -------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
CO
- -------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
CUSIP NO. 457985 10 9 13G/A Page 10 of 36 Pages
SCHEDULE 13G/A - TO BE INCLUDED IN STATEMENTS
FILED PURSUANT TO RULE 13d-1(c)
Item 1.
a) Name of Issuer:
Integra LifeSciences Corporation
b) Address of Issuer's Principal Office:
105 Morgan Lane
Plainsboro, New Jersey 08536
Item 2.
a) Name of Person filing:
The name of the person filing this statement is Richard E.
Caruso, Ph.D.
With respect to 14,401,611 shares, Dr. Caruso may be
deemed to share voting and dispositive powers with Pagliacci
Trust, Rigoletto Trust, Trust for Jonathan Henry Caruso and
Trust for Peter James Caruso (all of such Trusts being
Pennsylvania trusts), Provco Leasing Corporation, a Delaware
corporation, Trust Partnership, a Pennsylvania general
partnership, and Frances C. Holtz, a United States citizen,
all of which have filed a Schedule 13G/A herewith. The
relationship between Dr. Caruso and such entities and
individual is described below:
Trust Partnership is the record holder of 14,358,411
shares of Common Stock, par value $.01 per share, of Integra
LifeSciences Corporation that are the subject of this filing.
Dr. Caruso, Pagliacci Trust, Rigoletto Trust, Trust for
Jonathan Henry Caruso, Trust for Peter James Caruso and
Provco Leasing Corporation are the partners of Trust
Partnership. Frances C. Holtz, the sister of Dr. Caruso, is
the sole trustee of Pagliacci Trust and Rigoletto Trust and
is a co-trustee of Trust for Jonathan Henry Caruso and Trust
for Peter James Caruso. Each of such trusts is an irrevocable
trust whose beneficiaries are Dr. Caruso's children.
Provco Leasing Corporation, of which Dr. Caruso is
President, is a wholly-owned subsidiary of Cono Industries,
a corporation whose stockholders are trusts whose
<PAGE>
CUSIP NO. 457985 10 9 13G/A Page 11 of 36 Pages
beneficiaries include Dr. Caruso's children. Provco Leasing
Corporation beneficially owns 43,200 shares of common stock
of Integra LifeSciences Corporation, all of which are
issuable upon the exercise of the vested portion of
outstanding options held by Provco Leasing Corporation.
In addition to the foregoing beneficially owned shares,
Dr. Caruso also beneficially owns 47,600 shares of common
stock of Integra LifeSciences Corporation, all of which are
issuable upon the exercise of the vested portion of
outstanding options held by Dr. Caruso.
b) Address of Principal Business Office or, if None, Residence:
105 Morgan Lane
Plainsboro, New Jersey 08536
c) Citizenship:
United States Citizen
d) Title of Class of Securities:
Common Stock
e) CUSIP Number:
457985 10 9
Item 3. Not Applicable
Item 4. Ownership.
a) Amount Beneficially Owned:
14,449,211
b) Percent of Class:
50.4%
c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote:
47,600
<PAGE>
CUSIP NO. 457985 10 9 13G/A Page 12 of 36 Pages
(ii) shared power to vote or to direct the vote:
14,401,611
(iii) sole power to dispose or to direct the
disposition of:
47,600
(iv) shared power to dispose or to direct the
disposition of:
14,401,611
Item 5. Ownership of Five Percent or Less of a Class.
Not Applicable
Item 6. Ownership of More than Five Percent on Behalf of Another
Person.
See response to Item No. 2 for persons who may be deemed
to have the right to receive or the power to direct the
receipt of dividends from, or the proceeds from the sale
of, 14,401,611 shares of such securities (and such
interest relates to more than five percent of such
class).
Item 7. Identification and Classification of the Subsidiary Which
Acquired the Security Being Reported on by the Parent
Holding Company.
Not Applicable
Item 8. Identification and Classification of Members of a Group.
Exhibit A attached hereto identifies each member of the
group filing this Schedule 13G/A pursuant to Rule
13d-1(c).
Item 9. Notice of Dissolution of Group.
Not Applicable
Item 10. Certification.
Not Applicable
<PAGE>
CUSIP NO. 457985 10 9 13G/A Page 13 of 36 Pages
SCHEDULE 13G/A - TO BE INCLUDED IN STATEMENTS
FILED PURSUANT TO RULE 13d-1(c)
Item 1.
a) Name of Issuer:
Integra LifeSciences Corporation
b) Address of Issuer's Principal Office:
105 Morgan Lane
Plainsboro, New Jersey 08536
Item 2.
a) Name of Person filing:
The name of the person filing this statement is Frances
C. Holtz.
With respect to 14,358,411 shares, Frances C. Holtz may
be deemed to share voting and dispositive power with
Pagliacci Trust, Rigoletto Trust, Trust for Jonathan Henry
Caruso and Trust for Peter James Caruso (all of such trusts
being Pennsylvania trusts), Richard E. Caruso, Ph.D., Provco
Leasing Corporation, a Delaware Corporation, and Trust
Partnership, a Pennsylvania general partnership, all of which
have filed a Schedule 13G/A herewith. The relationship between
Frances C. Holtz and such entities and individual is
described below:
Dr. Caruso, Pagliacci Trust, Rigoletto Trust, Trust for
Jonathan Henry Caruso, Trust for Peter James Caruso and
Provco Leasing Corporation are the partners of Trust
Partnership. Trust Partnership is the record holder of
14,358,411 shares of common stock of Integra LifeSciences
Corporation that are the subject of this filing.
The Partnership Agreement of Trust Partnership requires
the approval of a majority in interest of its partners for
all Partnership actions, including the voting and disposition
of its shares of common stock of Integra LifeSciences
Corporation. Pagliacci Trust, Rigoletto Trust, Trust for
Jonathan Henry Caruso and Trust for Peter James Caruso hold a
majority in interest of Trust Partnership.
<PAGE>
CUSIP NO. 457985 10 9 13G/A Page 14 of 36 Pages
Frances C. Holtz is the sole trustee of Pagliacci Trust
and Rigoletto Trust and is a co-trustee of Trust for Jonathan
Henry Caruso and Trust for Peter James Caruso.
b) Address of Principal Business Office or, if None, Residence:
c/o Richard E. Caruso
105 Morgan Lane
Plainsboro, New Jersey 08536
c) Citizenship:
United States Citizen
d) Title of Class of Securities:
Common Stock
e) CUSIP Number:
457985 10 9
Item 3. Not Applicable
Item 4. Ownership.
a) Amount Beneficially Owned:
14,358,411
b) Percent of Class:
50.3%
c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote:
0
(ii) shared power to vote or to direct the vote:
14,358,411
(iii) sole power to dispose or to direct the
disposition of:
0
<PAGE>
CUSIP NO. 457985 10 9 13G/A Page 15 of 36 Pages
(iv) shared power to dispose or to direct the
disposition of:
14,358,411
Item 5. Ownership of Five Percent or Less of a Class.
Not Applicable
Item 6. Ownership of More than Five Percent on Behalf of Another
Person.
See response to Item No. 2 for persons who may be deemed
to have the right to receive or the power to direct the
receipt of dividends from, or the proceeds from the sale
of, 14,358,411 shares of such securities (and such
interest relates to more than five percent of such
class).
Item 7. Identification and Classification of the Subsidiary Which
Acquired the Security Being Reported on by the Parent
Holding Company.
Not Applicable
Item 8. Identification and Classification of Members of a Group.
Exhibit A attached hereto identifies each member of the
group filing this Schedule 13G/A pursuant to
Rule 13d-1(c).
Item 9. Notice of Dissolution of Group.
Not Applicable
Item 10. Certification.
Not Applicable
<PAGE>
CUSIP NO. 457985 10 9 13G/A Page 16 of 36 Pages
SCHEDULE 13G/A - TO BE INCLUDED IN STATEMENTS
FILED PURSUANT TO RULE 13d-1(c)
Item 1.
a) Name of Issuer:
Integra LifeSciences Corporation
b) Address of Issuer's Principal Office:
105 Morgan Lane
Plainsboro, New Jersey 08536
Item 2.
a) Name of Person filing:
The name of the person filing this statement is Trust
Partnership, a Pennsylvania general partnership.
b) Address of Principal Business Office or, if None, Residence:
c/o Richard E. Caruso
105 Morgan Lane
Plainsboro, New Jersey 08536
c) Citizenship:
Pennsylvania
d) Title of Class of Securities:
Common Stock
e) CUSIP Number:
457985 10 9
Item 3. Not Applicable
Item 4. Ownership.
a) Amount Beneficially Owned:
14,358,411
<PAGE>
CUSIP NO. 457985 10 9 13G/A Page 17 of 36 Pages
b) Percent of Class:
50.3%
c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote:
14,358,411
(ii) shared power to vote or to direct the vote:
0
(iii) sole power to dispose or to direct the
disposition of:
14,358,411
(iv) shared power to dispose or to direct the
disposition of:
0
Item 5. Ownership of Five Percent or Less of a Class.
Not Applicable
Item 6. Ownership of More than Five Percent on Behalf of Another
Person.
Not Applicable
Item 7. Identification and Classification of the Subsidiary Which
Acquired the Security Being Reported on by the Parent
Holding Company.
Not Applicable
Item 8. Identification and Classification of Members of a Group.
Exhibit A attached hereto identifies each member of the
group filing this Schedule 13G/A pursuant to
Rule 13d-1(c).
Item 9. Notice of Dissolution of Group.
Not Applicable
Item 10. Certification.
Not Applicable
<PAGE>
CUSIP NO. 457985 10 9 13G/A Page 18 of 36 Pages
SCHEDULE 13G/A - TO BE INCLUDED IN STATEMENTS
FILED PURSUANT TO RULE 13d-1(c)
Item 1.
a) Name of Issuer:
Integra LifeSciences Corporation
b) Address of Issuer's Principal Office:
105 Morgan Lane
Plainsboro, New Jersey 08536
Item 2.
a) Name of Person filing:
The name of the person filing this statement is Pagliacci
Trust.
With respect to 14,358,411 shares, Pagliacci Trust may be
deemed to share voting and dispositive power with Rigoletto
Trust, Trust for Jonathan Henry Caruso and Trust for Peter
James Caruso (all of such trusts being Pennsylvania trusts),
Provco Leasing Corporation, a Delaware corporation, Trust
Partnership, a Pennsylvania general partnership, and Richard
E. Caruso, Ph.D., a United States citizen, all of which have
filed a Schedule 13G/A herewith. The relationship between
Pagliacci Trust and such entities and individual is described
below:
Dr. Caruso, Pagliacci Trust, Rigoletto Trust, Trust for
Jonathan Henry Caruso, Trust for Peter James Caruso and
Provco Leasing Corporation are the partners of Trust
Partnership. Trust Partnership is the record holder of
14,358,411 shares of the Common Stock, par value $.01 per
share, of Integra LifeSciences Corporation that are the
subject of this filing.
b) Address of Principal Business Office or, if None, Residence:
c/o Richard E. Caruso
105 Morgan Lane
Plainsboro, New Jersey 08536
c) Citizenship:
Pennsylvania
<PAGE>
CUSIP NO. 457985 10 9 13G/A Page 19 of 36 Pages
d) Title of Class of Securities:
Common Stock
e) CUSIP Number:
457985 10 9
Item 3. Not Applicable
Item 4. Ownership.
a) Amount Beneficially Owned:
14,358,411
b) Percent of Class:
50.3%
c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote:
0
(ii) shared power to vote or to direct the vote:
14,358,411
(iii) sole power to dispose or to direct the
disposition of:
0
(iv) shared power to dispose or to direct the
disposition of:
14,358,411
Item 5. Ownership of Five Percent or Less of a Class.
Not Applicable
Item 6. Ownership of More than Five Percent on Behalf of Another
Person.
See response to Item No. 2 for persons who may be deemed
to have the right to receive or the power to direct the
receipt of dividends from, or the proceeds from the sale
<PAGE>
CUSIP NO. 457985 10 9 13G/A Page 20 of 36 Pages
of, 14,358,411 shares of such securities (and such
interest relates to more than five percent of such
class).
Item 7. Identification and Classification of the Subsidiary Which
Acquired the Security Being Reported on by the Parent
Holding Company.
Not Applicable
Item 8. Identification and Classification of Members of a Group.
Exhibit A attached hereto identifies each member of the
group filing this Schedule 13G/A pursuant to
Rule 13d-1(c).
Item 9. Notice of Dissolution of Group.
Not Applicable
Item 10. Certification.
Not Applicable
<PAGE>
CUSIP NO. 457985 10 9 13G/A Page 21 of 36 Pages
SCHEDULE 13G/A - TO BE INCLUDED IN STATEMENTS
FILED PURSUANT TO RULE 13d-1(c)
Item 1.
a) Name of Issuer:
Integra LifeSciences Corporation
b) Address of Issuer's Principal Office:
105 Morgan Lane
Plainsboro, New Jersey 08536
Item 2.
a) Name of Person filing:
The name of the person filing this statement is Rigoletto
Trust.
With respect to 14,358,411 shares, Rigoletto Trust may be
deemed to share voting and dispositive power with Pagliacci
Trust, Trust for Jonathan Henry Caruso and Trust for Peter
James Caruso (all of such trusts being Pennsylvania trusts),
Provco Leasing Corporation, a Delaware corporation, Trust
Partnership, a Pennsylvania general partnership, and Richard
E. Caruso, Ph.D., a United States citizen, all of which have
filed a Schedule 13G/A herewith. The relationship between
Rigoletto Trust and such entities and individual is described
below:
Dr. Caruso, Pagliacci Trust, Rigoletto Trust, Trust for
Jonathan Henry Caruso, Trust for Peter James Caruso and
Provco Leasing Corporation are the partners of Trust
Partnership. Trust Partnership is the record holder of
14,358,411 shares of the Common Stock, par value $.01 per
share, of Integra LifeSciences Corporation that are the
subject of this filing.
b) Address of Principal Business Office or, if None, Residence:
c/o Richard E. Caruso
105 Morgan Lane
Plainsboro, New Jersey 08536
c) Citizenship:
Pennsylvania
<PAGE>
CUSIP NO. 457985 10 9 13G/A Page 22 of 36 Pages
d) Title of Class of Securities:
Common Stock
e) CUSIP Number:
457985 10 9
Item 3. Not Applicable
Item 4. Ownership.
a) Amount Beneficially Owned:
14,358,411
b) Percent of Class:
50.3%
c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote:
0
(ii) shared power to vote or to direct the vote:
14,358,411
(iii) sole power to dispose or to direct the
disposition of:
0
(iv) shared power to dispose or to direct the
disposition of:
14,358,411
Item 5. Ownership of Five Percent or Less of a Class.
Not Applicable
Item 6. Ownership of More than Five Percent on Behalf of Another
Person.
See response to Item No. 2 for persons who may be deemed
to have the right to receive or the power to direct the
receipt of dividends from, or the proceeds from the sale
<PAGE>
CUSIP NO. 457985 10 9 13G/A Page 23 of 36 Pages
of, 14,358,411 shares of such securities (and such
interest relates to more than five percent of such
class).
Item 7. Identification and Classification of the Subsidiary Which
Acquired the Security Being Reported on by the Parent
Holding Company.
Not Applicable
Item 8. Identification and Classification of Members of a Group.
Exhibit A attached hereto identifies each member of the
group filing this Schedule 13G/A pursuant to
Rule 13d-1(c).
Item 9. Notice of Dissolution of Group.
Not Applicable
Item 10. Certification.
Not Applicable
<PAGE>
CUSIP NO. 457985 10 9 13G/A Page 24 of 36 Pages
SCHEDULE 13G/A - TO BE INCLUDED IN STATEMENTS
FILED PURSUANT TO RULE 13d-1(c)
Item 1.
a) Name of Issuer:
Integra LifeSciences Corporation
b) Address of Issuer's Principal Office:
105 Morgan Lane
Plainsboro, New Jersey 08536
Item 2.
a) Name of Person filing:
The name of the person filing this statement is Trust for
Jonathan Henry Caruso.
With respect to 14,358,411 shares, Trust for Jonathan
Henry Caruso may be deemed to share voting and dispositive
power with Pagliacci Trust, Rigoletto Trust and Trust for
Peter James Caruso (all of such trusts being Pennsylvania
trusts), Provco Leasing Corporation, a Delaware corporation,
Trust Partnership, a Pennsylvania general partnership, and
Richard E. Caruso, Ph.D., a United States citizen, all of
which have filed a Schedule 13G/A herewith. The relationship
between Trust for Jonathan Henry Caruso and such entities and
individual is described below:
Dr. Caruso, Pagliacci Trust, Rigoletto Trust, Trust for
Jonathan Henry Caruso, Trust for Peter James Caruso and
Provco Leasing Corporation are the partners of Trust
Partnership. Trust Partnership is the record holder of
14,358,411 shares of the Common Stock, par value $.01 per
share, of Integra LifeSciences Corporation that are the
subject of this filing.
b) Address of Principal Business Office or, if None, Residence:
c/o Richard E. Caruso
105 Morgan Lane
Plainsboro, New Jersey 08536
c) Citizenship:
Pennsylvania
<PAGE>
CUSIP NO. 457985 10 9 13G/A Page 25 of 36 Pages
d) Title of Class of Securities:
Common Stock
e) CUSIP Number:
457985 10 9
Item 3. Not Applicable
Item 4. Ownership.
a) Amount Beneficially Owned:
14,358,411
b) Percent of Class:
50.3%
c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote:
0
(ii) shared power to vote or to direct the vote:
14,358,411
(iii) sole power to dispose or to direct the
disposition of:
0
(iv) shared power to dispose or to direct the
disposition of:
14,358,411
Item 5. Ownership of Five Percent or Less of a Class.
Not Applicable
Item 6. Ownership of More than Five Percent on Behalf of Another
Person.
See response to Item No. 2 for persons who may be deemed
to have the right to receive or the power to direct the
receipt of dividends from, or the proceeds from the sale
<PAGE>
CUSIP NO. 457985 10 9 13G/A Page 26 of 36 Pages
of, 14,358,411 shares of such securities (and such
interest relates to more than five percent of such
class).
Item 7. Identification and Classification of the Subsidiary Which
Acquired the Security Being Reported on by the Parent
Holding Company.
Not Applicable
Item 8. Identification and Classification of Members of a Group.
Exhibit A attached hereto identifies each member of the
group filing this Schedule 13G/A pursuant to
Rule 13d-1(c).
Item 9. Notice of Dissolution of Group.
Not Applicable
Item 10. Certification.
Not Applicable
<PAGE>
CUSIP NO. 457985 10 9 13G/A Page 27 of 36 Pages
SCHEDULE 13G/A - TO BE INCLUDED IN STATEMENTS
FILED PURSUANT TO RULE 13d-1(c)
Item 1.
a) Name of Issuer:
Integra LifeSciences Corporation
b) Address of Issuer's Principal Office:
105 Morgan Lane
Plainsboro, New Jersey 08536
Item 2.
a) Name of Person filing:
The name of the person filing this statement is Trust for
Peter James Caruso.
With respect to 14,358,411 shares, Trust for Peter James
Caruso may be deemed to share voting and dispositive power
with Pagliacci Trust, Rigoletto Trust and Trust for Jonathan
Henry Caruso (all of such trusts being Pennsylvania trusts),
Provco Leasing Corporation, a Delaware corporation, Trust
Partnership, a Pennsylvania general partnership, and Richard
E. Caruso, Ph.D., a United States citizen, all of which have
filed a Schedule 13G/A herewith. The relationship between
Trust for Peter James Caruso and such entities and
individual is described below:
Dr. Caruso, Pagliacci Trust, Rigoletto Trust, Trust for
Jonathan Henry Caruso, Trust for Peter James Caruso and
Provco Leasing Corporation are the partners of Trust
Partnership. Trust Partnership is the record holder of
14,358,411 shares of the Common Stock, par value $.01 per
share, of Integra LifeSciences Corporation that are the
subject of this filing.
b) Address of Principal Business Office or, if None, Residence:
c/o Richard E. Caruso
105 Morgan Lane
Plainsboro, New Jersey 08536
c) Citizenship:
Pennsylvania
<PAGE>
CUSIP NO. 457985 10 9 13G/A Page 28 of 36 Pages
d) Title of Class of Securities:
Common Stock
e) CUSIP Number:
457985 10 9
Item 3. Not Applicable
Item 4. Ownership.
a) Amount Beneficially Owned:
14,358,411
b) Percent of Class:
50.3%
c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote:
0
(ii) shared power to vote or to direct the vote:
14,358,411
(iii) sole power to dispose or to direct the
disposition of:
0
(iv) shared power to dispose or to direct the
disposition of:
14,358,411
Item 5. Ownership of Five Percent or Less of a Class.
Not Applicable
Item 6. Ownership of More than Five Percent on Behalf of Another
Person.
See response to Item No. 2 for persons who may be deemed
to have the right to receive or the power to direct, the
receipt of dividends from, or the proceeds from the sale
<PAGE>
CUSIP NO. 457985 10 9 13G/A Page 29 of 36 Pages
of, 14,358,411 shares of such securities (and such
interest relates to more than five percent of such
class).
Item 7. Identification and Classification of the Subsidiary Which
Acquired the Security Being Reported on by the Parent
Holding Company.
Not Applicable
Item 8. Identification and Classification of Members of a Group.
Exhibit A attached hereto identifies each member of the
group filing this Schedule 13G/A pursuant to
Rule 13d-1(c).
Item 9. Notice of Dissolution of Group.
Not Applicable
Item 10. Certification.
Not Applicable
<PAGE>
CUSIP NO. 457985 10 9 13G/A Page 30 of 36 Pages
SCHEDULE 13G/A - TO BE INCLUDED IN STATEMENTS
FILED PURSUANT TO RULE 13d-1(c)
Item 1.
a) Name of Issuer:
Integra LifeSciences Corporation
b) Address of Issuer's Principal Office:
105 Morgan Lane
Plainsboro, New Jersey 08536
Item 2.
a) Name of Person filing:
The name of the person filing this statement is Provco
Leasing Corporation.
With respect to 14,358,411 shares, Provco Leasing
Corporation, a Delaware corporation, may be deemed to share
voting and dispositive power with Pagliacci Trust, Rigoletto
Trust, Trust for Jonathan Henry Caruso and Trust for Peter
James Caruso (all of such trusts being Pennsylvania trusts),
Trust Partnership, a Pennsylvania general partnership, and
Richard E. Caruso, Ph.D., a United States citizen, all of
which have filed a Schedule 13G/A herewith. The relationship
between Provco Leasing Corporation and such entities and
individual is described below:
Dr. Caruso, Pagliacci Trust, Rigoletto Trust, Trust for
Jonathan Henry Caruso, Trust for Peter James Caruso and
Provco Leasing Corporation are the partners of Trust
Partnership. Trust Partnership is the record holder of
14,358,411 shares of the Common Stock, par value $.01 per
share, of Integra LifeSciences Corporation that are the
subject of this filing.
Provco Leasing Corporation beneficially owns 43,200
shares of common stock of Integra LifeSciences Corporation,
all of which are issuable upon exercise of the vested portion
of outstanding options held by Provco Leasing Corporation.
<PAGE>
CUSIP NO. 457985 10 9 13G/A Page 31 of 36 Pages
b) Address of Principal Business Office or, if None, Residence:
Suite 314
King of Prussia Road
Radnor, Pennsylvania 19087
c) Citizenship:
Delaware
d) Title of Class of Securities:
Common Stock
e) CUSIP Number:
457985 10 9
Item 3. Not Applicable
Item 4. Ownership.
a) Amount Beneficially Owned:
14,401,611
b) Percent of Class:
50.4%
c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote:
43,200
(ii) shared power to vote or to direct the vote:
14,358,411
(iii) sole power to dispose or to direct the
disposition of:
43,200
<PAGE>
CUSIP NO. 457985 10 9 13G/A Page 32 of 36 Pages
(iv) shared power to dispose or to direct the
disposition of:
14,358,411
Item 5. Ownership of Five Percent or Less of a Class.
Not Applicable
Item 6. Ownership of More than Five Percent on Behalf of Another
Person.
See response to Item No. 2 for persons who may be deemed
to have the right to receive or the power to direct the
receipt of dividends from, or the proceeds from the sale
of, 14,358,411 shares of such securities (and such
interest relates to more than five percent of such
class).
Item 7. Identification and Classification of the Subsidiary Which
Acquired the Security Being Reported on by the Parent
Holding Company.
Not Applicable
Item 8. Identification and Classification of Members of a Group.
Exhibit A attached hereto identifies each member of the
group filing this Schedule 13G/A pursuant to
Rule 13d-1(c).
Item 9. Notice of Dissolution of Group.
Not Applicable
Item 10. Certification.
Not Applicable
<PAGE>
CUSIP NO. 457985 10 9 13G/A Page 33 of 36 Pages
SIGNATURES
After reasonable inquiry and to the best of our knowledge and
belief, we certify that the information set forth in this statement is true,
complete and correct.
Dated: March 13, 1997
RIGOLETTO TRUST
/s/ Richard E. Caruso By: /s/ Frances C. Holtz
- ------------------------- ------------------------------
Richard E. Caruso, Ph.D. Frances C. Holtz
Trustee
/s/ Frances C. Holtz
- -------------------------
Frances C. Holtz
TRUST FOR JONATHAN HENRY CARUSO
By: /s/ Frances C. Holtz
------------------------------
Frances C. Holtz
TRUST PARTNERSHIP Trustee
By /s/ Richard E. Caruso
----------------------
Richard E. Caruso
President and Partner
TRUST FOR PETER JAMES CARUSO
By: /s/ Frances C. Holtz
------------------------------
PAGLIACCI TRUST Frances C. Holtz
Trustee
By: /s/ Frances C. Holtz
---------------------
Frances C. Holtz
Trustee
PROVCO LEASING CORPORATION
By: /s/ Richard E. Caruso
------------------------------
Richard E. Caruso
President
<PAGE>
CUSIP NO. 457985 10 9 13G/A Page 34 of 36 Pages
EXHIBIT INDEX
Exhibit Title Page No.
- ------- ----- --------
Exhibit A Group Members Page 35
Exhibit B Joint Filing Agreement Page 36
<PAGE>
CUSIP NO. 457985 10 9 13G/A Page 35 of 36 Pages
EXHIBIT A
GROUP MEMBERS
Richard E. Caruso
Frances C. Holtz
Trust Partnership
Pagliacci Trust
Rigoletto Trust
Trust for Jonathan Henry Caruso
Trust for Peter James Caruso
Provco Leasing Corporation
<PAGE>
CUSIP NO. 457985 10 9 13G/A Page 36 of 36 Pages
EXHIBIT B
JOINT FILING AGREEMENT
In accordance with the Rule 13d-1(f) under the Securities Exchange Act
of 1934, as amended, the persons named below agree to the joint filing on
behalf of each of them of a Statement on Schedule 13G/A (including amendments
thereto) with respect to the Common Stock, par value $0.01 per share, of
Integra LifeSciences Corporation, and further agree that this Joint Filing
Agreement be included as an Exhibit to such joint filings. In evidence thereof,
the undersigned, being duly authorized, have executed this Joint Filing
Agreement this 13th day of March, 1997.
RIGOLETTO TRUST
/s/ Richard E. Caruso By: /s/ Frances C. Holtz
- -------------------------- ----------------------------
Richard E. Caruso, Ph.D. Frances C. Holtz
Trustee
/s/ Frances C. Holtz
- --------------------------
Frances C. Holtz
TRUST FOR JONATHAN HENRY CARUSO
By: /s/ Frances C. Holtz
----------------------------
Frances C. Holtz
TRUST PARTNERSHIP Trustee
By /s/ Richard E. Caruso
-----------------------
Richard E. Caruso
President and Partner
TRUST FOR PETER JAMES CARUSO
By: /s/ Frances C. Holtz
----------------------------
PAGLIACCI TRUST Frances C. Holtz
Trustee
By: /s/ Frances C. Holtz
----------------------
Frances C. Holtz
Trustee
PROVCO LEASING CORPORATION
By: /s/ Richard E. Caruso
----------------------------
Richard E. Caruso
President